GERN

Geron Corp

NASDAQ · Biotechnology

$1.53

+0.07 (+4.79%)

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Buy

13 analysts

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target +1,142.5% upside

Low Target $12.94

Average Target $19.01

High Target $24.33

Current Price $1.53

Current
$1.53

Target
$19.01

$12.94 $19.01 avg $24.33